FormFactor secures $300 million equity investment from Teradyne in new testing partnership
FormFactor announced a technology partnership with Teradyne that includes a $300 million equity infusion from the test‑equipment maker. The deal combines FormFactor’s probe and interface solutions with Teradyne’s automated test platforms to serve high‑performance compute, advanced packaging and AI‑driven semiconductor applications. Both CEOs said the collaboration will help customers accelerate product development and scale production. The transaction awaits customary closing conditions and regulatory clearance.
Why it matters
The cash injection provides FormFactor with significant funding to expand its testing portfolio, while the equity purchase may dilute existing shareholders. The announcement lifted FormFactor’s after‑hours share price by about 3.6%, indicating market support for the partnership.
Key facts
- 1Teradyne will invest $300 million in FormFactor common stock. investing.com
- 2The investment is conditional on standard closing requirements and regulatory approvals. investing.com
- 3FormFactor shares rose roughly 3.6% in after‑hours trading following the announcement. investing.com
- 4Mike Slessor, FormFactor CEO, said the partnership will help customers move faster from development to high‑volume manufacturing. investing.com
- 5Gregory Smith, Teradyne CEO, said the deal creates a more complete testing path for advanced packaging, silicon photonics and memory challenges. investing.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.